Literature DB >> 30363389

Delayed Hypersensitivity Reaction to OnabotulinumtoxinA.

Peter A LeWitt1,2.   

Abstract

http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2330-1619/homepage/mdc312575-sup-v001.htm.

Entities:  

Keywords:  anaphylaxis; botulinum toxin; hypersensitivity; onabotulinumtoxinA

Year:  2018        PMID： 30363389      PMCID： PMC6174445          DOI： 10.1002/mdc3.12575

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


  9 in total

Review 1.  Safety of botulinum toxin type A: a systematic review and meta-analysis.

Authors:  Markus Naumann; Joseph Jankovic
Journal:  Curr Med Res Opin       Date:  2004-07       Impact factor: 2.580

2.  Anaphylaxis--a practice parameter update 2015.

Authors:  Phillip Lieberman; Richard A Nicklas; Christopher Randolph; John Oppenheimer; David Bernstein; Jonathan Bernstein; Anne Ellis; David B K Golden; Paul Greenberger; Steven Kemp; David Khan; Dennis Ledford; Jay Lieberman; Dean Metcalfe; Anna Nowak-Wegrzyn; Scott Sicherer; Dana Wallace; Joann Blessing-Moore; David Lang; Jay M Portnoy; Diane Schuller; Sheldon Spector; Stephen A Tilles
Journal:  Ann Allergy Asthma Immunol       Date:  2015-11       Impact factor: 6.347

3.  First case of anaphylaxis after botulinum toxin type A injection.

Authors:  I J Moon; S E Chang; S D Kim
Journal:  Clin Exp Dermatol       Date:  2017-06-21       Impact factor: 3.470

4.  Fatal case of BOTOX-related anaphylaxis?

Authors:  Melissa Li; Bruce A Goldberger; Carolyn Hopkins
Journal:  J Forensic Sci       Date:  2005-01       Impact factor: 1.832

5.  Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.

Authors:  Timothy R Coté; Aparna K Mohan; Jacquelyn A Polder; Marc K Walton; M Miles Braun
Journal:  J Am Acad Dermatol       Date:  2005-09       Impact factor: 11.527

6.  A new facial expression to botox!

Authors:  Aakash Aggarwal; Viren Kaul; Gurmeen Kaur; Emerald Banas; Praveen Sampath; Ajoy K Roy
Journal:  Am J Emerg Med       Date:  2013-10-14       Impact factor: 2.469

7.  Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection.

Authors:  P A LeWitt; R M Trosch
Journal:  Mov Disord       Date:  1997-11       Impact factor: 10.338

Review 8.  Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.

Authors:  Cidronio Albavera-Hernández; Jorge M Rodríguez; Alvaro J Idrovo
Journal:  Clin Rehabil       Date:  2009-04-23       Impact factor: 3.477

Review 9.  Clinical relevance of botulinum toxin immunogenicity.

Authors:  Reiner Benecke
Journal:  BioDrugs       Date:  2012-04-01       Impact factor: 5.807
  9 in total
  1 in total

Review 1.  Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia.

Authors:  Abdul Mueez Alam Kayani; Minollie Suzanne Silva; Maleesha Jayasinghe; Malay Singhal; Snigdha Karnakoti; Samiksha Jain; Rahul Jena
Journal:  Cureus       Date:  2022-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.